🇺🇸 gabapentin + tramadol in United States
11 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 11
Most-reported reactions
- Fatigue — 2 reports (18.18%)
- Breast Cancer — 1 report (9.09%)
- Chills — 1 report (9.09%)
- Decreased Appetite — 1 report (9.09%)
- Device Malfunction — 1 report (9.09%)
- Diarrhoea — 1 report (9.09%)
- Malaise — 1 report (9.09%)
- Multiple Sclerosis — 1 report (9.09%)
- Needle Issue — 1 report (9.09%)
- Pyrexia — 1 report (9.09%)
Other Pain Management approved in United States
Frequently asked questions
Is gabapentin + tramadol approved in United States?
gabapentin + tramadol does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for gabapentin + tramadol in United States?
Southwest Hospital, China is the originator. The local marketing authorisation holder may differ — check the official source linked above.